Literature DB >> 16490860

Rituximab-induced leukocytoclastic vasculitis: a case report.

Praveen Kandula, Peter A Kouides.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16490860     DOI: 10.1001/archderm.142.2.246

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


× No keyword cloud information.
  7 in total

Review 1.  Adverse reactions to biologic agents and their medical management.

Authors:  Onur Boyman; Denis Comte; François Spertini
Journal:  Nat Rev Rheumatol       Date:  2014-08-12       Impact factor: 20.543

2.  Unmasking the elusive giant: an unusual case presenting as third nerve palsy in a patient with scleroderma.

Authors:  Wan Lin Ng; John McManus; James Anthony Joseph Devlin; Alexander Fraser
Journal:  BMJ Case Rep       Date:  2016-04-11

Review 3.  Diagnosis and management of leukocytoclastic vasculitis.

Authors:  Paolo Fraticelli; Devis Benfaremo; Armando Gabrielli
Journal:  Intern Emerg Med       Date:  2021-03-13       Impact factor: 3.397

Review 4.  Adverse events to monoclonal antibodies used for cancer therapy: Focus on hypersensitivity responses.

Authors:  Brian A Baldo
Journal:  Oncoimmunology       Date:  2013-10-17       Impact factor: 8.110

Review 5.  Vasculitis induced by biological agents used in rheumatology practice: A systematic review.

Authors:  Camila da Silva Cendon Duran; Adriane Souza da Paz; Mittermayer Barreto Santiago
Journal:  Arch Rheumatol       Date:  2021-12-24       Impact factor: 1.007

Review 6.  Drug-Induced Vasculitis: New Insights and a Changing Lineup of Suspects.

Authors:  Rafael G Grau
Journal:  Curr Rheumatol Rep       Date:  2015-12       Impact factor: 4.686

Review 7.  Immune- and Non-Immune-Mediated Adverse Effects of Monoclonal Antibody Therapy: A Survey of 110 Approved Antibodies.

Authors:  Brian A Baldo
Journal:  Antibodies (Basel)       Date:  2022-02-25
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.